Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect

Liraglutide has shown favourable effects on several cardiometabolic risk factors, beyond glucose control. MicroRNAs (miRNAs) regulate gene expression, resulting in post-transcriptional modifications of cell response and function. Specific miRNAs, including miRNA-27b, miRNA-130a, and miRNA-210, play...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglio, Rosaria Vincenza, Nikolic, Dragana, Volti, Giovanni Li, Stoian, Anca Pantea, Banerjee, Yajnavalka, Magan-Fernandez, Antonio, Castellino, Giuseppa, Patti, Angelo Maria, Chianetta, Roberta, Castracani, Carlo Castruccio, Montalto, Giuseppe, Rizvi, Ali A., Sesti, Giorgio, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599907/
https://www.ncbi.nlm.nih.gov/pubmed/33008044
http://dx.doi.org/10.3390/metabo10100391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599907/
https://www.ncbi.nlm.nih.gov/pubmed/33008044
http://dx.doi.org/10.3390/metabo10100391

Ejemplares similares